FULCRUM THERAPEUTICS, INC.

FULC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020 Sep 2020
Assets
Cash & Equivalents $40.2M $33.3M $35.4M $65.5M $56.8M $100.7M $57.1M $85.2M
Accounts Receivable
Inventory
Total Current Assets $174.2M $200.1M $226.0M $246.2M $128.5M $147.0M $119.5M $132.1M
Property, Plant & Equipment $7.8M $7.9M $7.4M $7.7M $7.7M $7.8M $8.4M $8.4M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $195.2M $220.2M $235.0M $255.5M $137.9M $156.5M $129.6M $142.2M
Liabilities
Accounts Payable $5.4M $6.0M $4.8M $3.7M $4.5M $4.8M $4.1M $3.6M
Total Current Liabilities $22.1M $18.3M $19.2M $20.6M $22.5M $22.6M $26.7M $26.5M
Long-Term Debt
Total Liabilities $34.5M $31.1M $23.5M $24.9M $27.0M $28.7M $34.4M $37.2M
Stockholders' Equity
Retained Earnings $-362.5M $-328.4M $-302.5M $-279.0M $-258.3M $-238.6M $-221.6M $-203.9M
Total Stockholders' Equity $160.8M $189.2M $211.5M $230.6M $110.9M $127.8M $95.2M $105.0M
← Newer Page 3 of 4 Older →